Seeing Is Believing
Currently out of the existing stock ratings of Narumi Nakagiri, 4 are a HOLD (40%), 6 are a BUY (60%).
Analyst Narumi Nakagiri, currently employed at DAIWA, carries an average stock price target met ratio of 80% that have a potential upside of 9.06% achieved within 111 days.
Narumi Nakagiri’s has documented 21 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on JNJ, Johnson & Johnson at 20-Oct-2025.
Analyst best performing recommendations are on JNJ (JOHNSON & JOHNSON).
The best stock recommendation documented was for JNJ (JOHNSON & JOHNSON) at 7/23/2024. The price target of $150 was fulfilled within 2 days with a profit of $5.22 (3.61%) receiving and performance score of 18.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-Jan-2025
$375
$27.06 (7.78%)
$325
1 months 20 days ago
(19-Feb-2026)
13/14 (92.86%)
$-0.5 (-0.13%)
284
Buy Since 02-Jan-2025
$432
$84.06 (24.16%)
$381
1 months 21 days ago
(18-Feb-2026)
9/10 (90%)
$52.27 (13.77%)
150
Buy Since 06-Feb-2023
$400
$52.06 (14.96%)
$270
2 months 2 days ago
(06-Feb-2026)
1/2 (50%)
$18.32 (4.80%)
330
Hold Since 20-May-2025
$347
$-0.94 (-0.27%)
$288
2 months 2 days ago
(06-Feb-2026)
1/2 (50%)
$-34.68 (-9.09%)
23
Hold Since 10-Feb-2022
$309
$-38.94 (-11.19%)
$304
2 months 4 days ago
(04-Feb-2026)
19/21 (90.48%)
$-54.68 (-15.04%)
714
Which stock is Narumi Nakagiri is most bullish on?
What Year was the first public recommendation made by Narumi Nakagiri?